Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Frank Sauer has worked on the following 49 EPO patent applications which have been published in the last five years:

EP12709329

BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE

IPC classification:
A61K 31/553, A61P 3/00, A61P 5/00, A61P 19/00, A61P 25/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 498/04, C07D 498/14, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12721812

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/502, A61P 29/00, A61P 37/00, C07D 401/10, C07D 401/14, C07D 403/10, C07D 405/10, C07D 413/10, C07D 417/10, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12726085

METHODS OF TREATING MESOTHELIOMA WITH A PI3K INHIBITOR COMPOUND

IPC classification:
A61K 31/519, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12750354

INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/416, A61K 31/4439, A61P 37/00, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12748200

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/4725, A61P 19/02, C07D 401/14, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12781301

AZETIDINE COMPOUNDS, COMPOSITIONS AND THEIR USE AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

IPC classification:
A61K 31/397, A61P 13/00, A61P 15/00, C07D 487/04, C07D 487/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783837

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY

IPC classification:
A61K 31/381, A61K 31/4353, A61K 31/4985, A61P 35/00, A61P 37/00, C07D 471/04, C07D 471/14, C07D 487/04, C07D 487/14, C07D 495/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783838

ALKYLATED PIPERAZINE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY

IPC classification:
A61K 31/381, A61K 31/4985, A61P 35/00, A61P 37/00, C07D 471/04, C07D 495/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12795138

BICYCLIC PIPERAZINE COMPOUNDS

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/5025, A61K 31/52, A61P 9/00, A61P 31/12, A61P 35/00, A61P 37/02, C07D 471/04, C07D 487/04, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783834

8-FLUOROPHTHALAZIN-1 (2H) - ONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY

IPC classification:
A61K 31/502, A61P 35/00, A61P 37/00, C07D 401/10, C07D 401/14, C07D 405/14, C07D 413/14, C07D 487/04, C07D 498/04, C07D 513/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14159449

Benzoxepin pi3k inhibitor compounds and methods of use

IPC classification:
A61K 31/381, A61K 31/429, A61P 35/00, C07D 495/04, C07D 495/14, C07D 513/04, C07D 513/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12795824

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/5025, A61P 29/00, C07D 471/04, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13193562

Benzoxazepin PI3K inhibitor compounds and methods of use

IPC classification:
A61K 31/4162, A61K 31/4188, A61K 31/4196, A61P 35/00, C07D 498/04, C07D 498/14, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14177962

Tricyclic PI3K inhibitor compounds and methods of use

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/14, C07D 491/14, C07D 495/14, C07D 498/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14190276

Benzoxazepin PI3K inhibitor compounds and methods of use

IPC classification:
A61K 31/4162, A61K 31/4188, A61K 31/4196, A61K 31/553, A61K 45/06, A61P 35/00, C07D 498/04, C07D 498/14, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13724574

COMPOSITIONS AND METHODS OF OBTAINING AND USING ENDODERM AND HEPATOCYTE CELLS

IPC classification:
C12N 5/071, C12N 5/074
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13729649

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/138, A61K 31/337, A61K 31/357, A61K 31/4196, A61K 31/4523, A61K 31/513, A61K 31/553, A61K 31/555, A61K 31/565, A61K 31/573, A61K 31/7068, A61K 39/00, A61K 45/06, C12Q 1/68, G01N 33/48
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13827574

PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/416, A61P 37/00, C07D 231/56
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753637

DIOXINO- AND OXAZIN-[2,3-D]PYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/519, A61K 31/527, A61K 31/5383, A61K 31/5386, A61P 29/00, A61P 35/00, C07D 491/04, C07D 498/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13759240

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/502, A61P 11/06, A61P 19/02, A61P 29/00, C07D 401/14, C07D 403/14, C07D 413/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13774174

PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13791795

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/407, A61K 31/4412, A61K 31/502, A61P 19/02, A61P 29/02, C07D 211/82, C07D 401/10, C07D 401/12, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13798637

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/4725, A61K 31/501, A61K 31/502, A61K 45/06, A61P 11/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13805327

THIAZOLE DERIVATIVES AS INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/445, A61P 19/00, A61P 29/00, A61P 37/00, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14707402

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
C07D 413/14, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14709585

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/52, A61P 11/06, C07D 473/16, C07D 473/34
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14707399

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14709314

PROCESS FOR MAKING BENZOXAZEPIN COMPOUNDS

IPC classification:
A61K 31/4162, C07D 498/04
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14713849

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/519, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14722170

PROCESS FOR THE PREPARATION OF BORONIC ACID INTERMEDIATES

IPC classification:
C07D 495/04, C07F 5/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP15188086

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY

IPC classification:
A61K 31/381, A61K 31/4353, A61K 31/4985, A61P 35/00, A61P 37/00, C07D 471/04, C07D 471/14, C07D 487/04, C07D 487/14, C07D 495/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11704604

PYRIDO[3,2-D]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/519, A61P 35/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14734486

HETEROARYL PYRIDONE AND AZA-PYRIDONE AMIDE COMPOUNDS

IPC classification:
A61K 31/407, A61K 31/4184, A61K 31/4365, A61K 31/437, A61K 31/4985, A61K 31/502, A61K 31/5025, A61P 35/00, A61P 37/00, C07D 401/10, C07D 401/14, C07D 471/04, C07D 471/14, C07D 487/04, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12704739

HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS

IPC classification:
C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 471/04, C07D 473/16, C07D 473/32, C07D 473/34, C07D 473/40, C07D 487/04, C07D 495/04, C07D 498/06, C07D 513/02, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11808454

TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/14, C07D 491/14, C07D 495/14, C07D 498/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16151410

TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/14, C07D 491/14, C07D 495/14, C07D 498/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP11746518

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
C07D 405/14, C07D 413/14, C07D 417/14, C07D 487/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12192150

TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/41, A61K 31/497, A61P 11/00, A61P 13/02, A61P 29/00, C07D 257/08, C07D 403/10, C07D 403/12, C07D 403/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12195604

Triazole-substituted arylamide derivatives and their use as P2x3 and /or P2x2/3 purinergic receptor antagonists

IPC classification:
A61K 31/4192, A61K 31/497, A61P 11/00, A61P 13/02, A61P 29/00, C07D 249/06, C07D 401/14, C07D 403/12, C07D 403/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11736322

PURINE COMPOUNDS SELECTIVE FOR I3 P110 DELTA, AND METHODS OF USE

IPC classification:
A61K 31/52, A61P 35/00, C07D 473/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14808596

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS WITH ELECTROPHILIC FUNCTIONALITY

IPC classification:
A61K 31/5025, A61P 35/00, A61P 37/00, C07D 401/14, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14809645

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/4155, A61K 31/4439, A61P 11/06, A61P 29/00, C07D 401/14, C07D 403/06, C07D 403/14
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14809643

INHIBITORS OF BRUTON'S TYROSINE KINASE

IPC classification:
A61K 31/4155, A61K 31/4439, A61P 11/06, A61P 29/00, C07D 401/14, C07D 403/06
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14811921

POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF

IPC classification:
A61K 31/4196, A61P 35/00, C07D 498/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15701232

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61K 31/435, A61P 31/12, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721009

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61K 31/4375, A61P 31/20, C07D 455/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15723238

METHODS OF TREATING PR-POSITIVE, LUMINAL A BREAST CANCER WITH PI3K INHIBITOR, PICTILISIB

IPC classification:
A61K 31/381, A61K 31/495, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15750039

NOVEL PYRIDAZONES AND TRIAZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

IPC classification:
A61K 31/53, A61P 31/20, C07D 237/04, C07D 237/14, C07D 253/06, C07D 253/07
Applicant:
F. Hoffmann-La Roche AG
Agent:
Frank Sauer, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature